Back to Search Start Over

This title is unavailable for guests, please login to see more information.

Authors :
KUMAMOTO, Yoshiaki
TSUKAMOTO, Taiji
SAKAI, Shigeru
MAEKAWA, Sizue
OGUMA, Keiji
IGAWA, Kinichi
SHIMAMURA, Shougo
TANAKA, Noriaki
GOURO, Tsutomu
HENMI, Izumi
KADONO, Masao
OKAYAMA, Satoru
MIYAKE, Masaumi
HONNMA, Akio
KATO, Shuji
TANDA, Hitoshi
MARUTA, Hiroshi
MIKUMA, Naoto
ITO, Naoki
UJIIE, Toru
FUJITA, Masataka
YAMAZAKI, Kiyohirto
MIYAMOTO, Shinichi
TAMIYA, Takahiro
ENATSU, Chosho
IWASAKI, Akihiko
YOKOYAMA, Eiji
NISHIMURA, Masahiro
AOKI, Masaji
NANNBU, Akitami
KUMAMOTO, Yoshiaki
TSUKAMOTO, Taiji
SAKAI, Shigeru
MAEKAWA, Sizue
OGUMA, Keiji
IGAWA, Kinichi
SHIMAMURA, Shougo
TANAKA, Noriaki
GOURO, Tsutomu
HENMI, Izumi
KADONO, Masao
OKAYAMA, Satoru
MIYAKE, Masaumi
HONNMA, Akio
KATO, Shuji
TANDA, Hitoshi
MARUTA, Hiroshi
MIKUMA, Naoto
ITO, Naoki
UJIIE, Toru
FUJITA, Masataka
YAMAZAKI, Kiyohirto
MIYAMOTO, Shinichi
TAMIYA, Takahiro
ENATSU, Chosho
IWASAKI, Akihiko
YOKOYAMA, Eiji
NISHIMURA, Masahiro
AOKI, Masaji
NANNBU, Akitami
Publication Year :
1987

Abstract

The clinical efficacy of norfloxacin (NFLX) was evaluated in 74 patients having chronic prostatitis with the subjective symptoms suggesting the inflammations of prostate and more than five white bloodcells (WBCs)/hpf in their prostatic secretions (EPS). Of these, gram negative rods with greater than or equal to 10(3)CFU/ml (GNR group) were isolated from the EPS in 10 patients (13.6%) and gram positive cocci with greater than or equal to 10(3) CFU/ml (GPC group) were obtained in 46 patients (62.2%). E. coli (70.0%) was the most frequent strain isolated among GNR group and S. epidermidis (40.4%), S. aureus (19.1%), E. faecalis (17.0%) and S. haemolyticus (14.9%) were frequently isolated among the GPC group. The overall clinical efficacy of NFLX was determined at the second and fourth week by the three factors, (1) the effect on bacteria, (2) WBCs in the EPS and (3) the subjective symptoms in the patients with bacteria of greater than or equal to 10(3) CFU/ml being isolated. The overall clinical effectiveness rate was 71.4% and 100%, respectively, in the GNR group. In the GPC group, its rate was 79.3% and 88.0%, respectively. The patients with no bacteria or less than 10(3) CFU/ml isolated from the EPS had an overall clinical effectiveness rate of 89.8% at the second week and 90.0% at the fourth, when it was evaluated by the effect on WBCs and subjective symptoms. In the effect of NFLX on bacteria in the EPS, it eliminated them in 75.0% and 83.9% at the second and fourth week, respectively, of all patients with GNR or GPC of greater than or equal to 10(3) CFU/ml isolated from the EPS. The minimum inhibitory concentrations (MIC) of NFLX against E. coli isolated from the EPS was distributed from 0.025 microgram/ml to 3.13 micrograms/ml with most below 0.1 microgram/ml. Those against all other GNR were below 0.78 microgram/ml. NFLX showed good antimicrobial activities against GPC with most of MIC being distributed from 0.78 microgram/ml to 1.56 micrograms/ml. NFLX produce

Details

Database :
OAIster
Notes :
Japanese
Accession number :
edsoai.ocn957867525